Cargando…

The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension

The Na(+)-activated Na(+) channel (Nax) and salt-inducible kinase (SIK) are stimulated by increases in local Na(+) concentration, affecting (Na(+) + K(+))-ATPase activity. To test the hypothesis that the triad Nax/SIK/(Na(+) + K(+))-ATPase contributes to kidney injury and salt-sensitive hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonsalez, Sabrina R., Gomes, Dayene S., de Souza, Alessandro M., Ferrão, Fernanda M., Vallotton, Zoe, Gogulamudi, Venkateswara R., Lowe, Jennifer, Casarini, Dulce E., Prieto, Minolfa C., Lara, Lucienne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178781/
https://www.ncbi.nlm.nih.gov/pubmed/37175599
http://dx.doi.org/10.3390/ijms24097887
_version_ 1785040941799702528
author Gonsalez, Sabrina R.
Gomes, Dayene S.
de Souza, Alessandro M.
Ferrão, Fernanda M.
Vallotton, Zoe
Gogulamudi, Venkateswara R.
Lowe, Jennifer
Casarini, Dulce E.
Prieto, Minolfa C.
Lara, Lucienne S.
author_facet Gonsalez, Sabrina R.
Gomes, Dayene S.
de Souza, Alessandro M.
Ferrão, Fernanda M.
Vallotton, Zoe
Gogulamudi, Venkateswara R.
Lowe, Jennifer
Casarini, Dulce E.
Prieto, Minolfa C.
Lara, Lucienne S.
author_sort Gonsalez, Sabrina R.
collection PubMed
description The Na(+)-activated Na(+) channel (Nax) and salt-inducible kinase (SIK) are stimulated by increases in local Na(+) concentration, affecting (Na(+) + K(+))-ATPase activity. To test the hypothesis that the triad Nax/SIK/(Na(+) + K(+))-ATPase contributes to kidney injury and salt-sensitive hypertension (HTN), uninephrectomized male Wistar rats (200 g; n = 20) were randomly divided into 4 groups based on a salt diet (normal salt diet; NSD—0.5% NaCl—or high-salt diet; HSD—4% NaCl) and subcutaneous administration of saline (0.9% NaCl) or deoxycorticosterone acetate (DOCA, 8 mg/kg), as follows: Control (CTRL), CTRL-Salt, DOCA, and DOCA-Salt, respectively. After 28 days, the following were measured: kidney function, blood pressure, (Na(+) + K(+))-ATPase and SIK1 kidney activities, and Nax and SIK1 renal expression levels. SIK isoforms in kidneys of CTRL rats were present in the glomerulus and tubular epithelia; they were not altered by HSD and/or HTN. CTRL-Salt rats remained normotensive but presented slight kidney function decay. HSD rats displayed augmentation of the Nax/SIK/(Na(+) + K(+))-ATPase pathway. HTN, kidney injury, and kidney function decay were present in all DOCA rats; these were aggravated by HSD. DOCA rats presented unaltered (Na(+) + K(+))-ATPase activity, diminished total SIK activity, and augmented SIK1 and Nax content in the kidney cortex. DOCA-Salt rats expressed SIK1 activity and downregulation in (Na(+) + K(+))-ATPase activity in the kidney cortex despite augmented Nax content. The data of this study indicate that the (Na(+) + K(+))-ATPase activity response to SIK is attenuated in rats under HSD, independent of HTN, as a mechanism contributing to kidney injury and salt-sensitive HTN.
format Online
Article
Text
id pubmed-10178781
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101787812023-05-13 The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension Gonsalez, Sabrina R. Gomes, Dayene S. de Souza, Alessandro M. Ferrão, Fernanda M. Vallotton, Zoe Gogulamudi, Venkateswara R. Lowe, Jennifer Casarini, Dulce E. Prieto, Minolfa C. Lara, Lucienne S. Int J Mol Sci Article The Na(+)-activated Na(+) channel (Nax) and salt-inducible kinase (SIK) are stimulated by increases in local Na(+) concentration, affecting (Na(+) + K(+))-ATPase activity. To test the hypothesis that the triad Nax/SIK/(Na(+) + K(+))-ATPase contributes to kidney injury and salt-sensitive hypertension (HTN), uninephrectomized male Wistar rats (200 g; n = 20) were randomly divided into 4 groups based on a salt diet (normal salt diet; NSD—0.5% NaCl—or high-salt diet; HSD—4% NaCl) and subcutaneous administration of saline (0.9% NaCl) or deoxycorticosterone acetate (DOCA, 8 mg/kg), as follows: Control (CTRL), CTRL-Salt, DOCA, and DOCA-Salt, respectively. After 28 days, the following were measured: kidney function, blood pressure, (Na(+) + K(+))-ATPase and SIK1 kidney activities, and Nax and SIK1 renal expression levels. SIK isoforms in kidneys of CTRL rats were present in the glomerulus and tubular epithelia; they were not altered by HSD and/or HTN. CTRL-Salt rats remained normotensive but presented slight kidney function decay. HSD rats displayed augmentation of the Nax/SIK/(Na(+) + K(+))-ATPase pathway. HTN, kidney injury, and kidney function decay were present in all DOCA rats; these were aggravated by HSD. DOCA rats presented unaltered (Na(+) + K(+))-ATPase activity, diminished total SIK activity, and augmented SIK1 and Nax content in the kidney cortex. DOCA-Salt rats expressed SIK1 activity and downregulation in (Na(+) + K(+))-ATPase activity in the kidney cortex despite augmented Nax content. The data of this study indicate that the (Na(+) + K(+))-ATPase activity response to SIK is attenuated in rats under HSD, independent of HTN, as a mechanism contributing to kidney injury and salt-sensitive HTN. MDPI 2023-04-26 /pmc/articles/PMC10178781/ /pubmed/37175599 http://dx.doi.org/10.3390/ijms24097887 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gonsalez, Sabrina R.
Gomes, Dayene S.
de Souza, Alessandro M.
Ferrão, Fernanda M.
Vallotton, Zoe
Gogulamudi, Venkateswara R.
Lowe, Jennifer
Casarini, Dulce E.
Prieto, Minolfa C.
Lara, Lucienne S.
The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension
title The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension
title_full The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension
title_fullStr The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension
title_full_unstemmed The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension
title_short The Triad Na(+) Activated Na(+) Channel (Nax)—Salt Inducible KINASE (SIK) and (Na(+) + K(+))-ATPase: Targeting the Villains to Treat Salt Resistant and Sensitive Hypertension
title_sort triad na(+) activated na(+) channel (nax)—salt inducible kinase (sik) and (na(+) + k(+))-atpase: targeting the villains to treat salt resistant and sensitive hypertension
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178781/
https://www.ncbi.nlm.nih.gov/pubmed/37175599
http://dx.doi.org/10.3390/ijms24097887
work_keys_str_mv AT gonsalezsabrinar thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT gomesdayenes thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT desouzaalessandrom thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT ferraofernandam thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT vallottonzoe thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT gogulamudivenkateswarar thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT lowejennifer thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT casarinidulcee thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT prietominolfac thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT laraluciennes thetriadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT gonsalezsabrinar triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT gomesdayenes triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT desouzaalessandrom triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT ferraofernandam triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT vallottonzoe triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT gogulamudivenkateswarar triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT lowejennifer triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT casarinidulcee triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT prietominolfac triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension
AT laraluciennes triadnaactivatednachannelnaxsaltinduciblekinasesikandnakatpasetargetingthevillainstotreatsaltresistantandsensitivehypertension